Literature DB >> 7799394

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

M Boers1, P Tugwell, D T Felson, P L van Riel, J R Kirwan, J P Edmonds, J S Smolen, N Khaltaev, K D Muirden.   

Abstract

The WHO/ILAR core set of endpoints for rheumatoid arthritis clinical trials signifies progress in a continuing worldwide effort. This core set includes the following measures: pain, patient global assessment, physical disability, swollen joints, tender joints, acute phase reactants, and physician global assessment; in studies of one or more years' duration, radiographs of joints should be performed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7799394

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


  68 in total

1.  Health Assessment Questionnaire modifications: is standardisation needed?

Authors:  M M Zandbelt; P M Welsing; A M van Gestel; P L van Riel
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

Review 2.  "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.

Authors:  M C Hochberg; J K Tracy; R H Flores
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 3.  Interpreting radiographic data in rheumatoid arthritis.

Authors:  P A Ory
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

4.  The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 5.  Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis.

Authors:  M C Hochberg; J K Tracy; M Hawkins-Holt; R H Flores
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

6.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

7.  Validity and responsiveness of the Michigan Hand Questionnaire in patients with rheumatoid arthritis: a multicenter, international study.

Authors:  Jennifer F Waljee; Kevin C Chung; H Myra Kim; Patricia B Burns; Frank D Burke; E F Shaw Wilgis; David A Fox
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06-02       Impact factor: 4.794

Review 8.  The COMET Handbook: version 1.0.

Authors:  Paula R Williamson; Douglas G Altman; Heather Bagley; Karen L Barnes; Jane M Blazeby; Sara T Brookes; Mike Clarke; Elizabeth Gargon; Sarah Gorst; Nicola Harman; Jamie J Kirkham; Angus McNair; Cecilia A C Prinsen; Jochen Schmitt; Caroline B Terwee; Bridget Young
Journal:  Trials       Date:  2017-06-20       Impact factor: 2.279

Review 9.  Prevention or retardation of joint damage in rheumatoid arthritis: issues of definition, evaluation and interpretation of plain radiographs.

Authors:  Maarten Boers; Désirée M F M van der Heijde
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis.

Authors:  Manathip Osiri; Jeerapat Wongchinsri; Sitthichai Ukritchon; Punchong Hanvivadhanakul; Nuntana Kasitanon; Boonjing Siripaitoon
Journal:  Arthritis Res Ther       Date:  2009-08-27       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.